南美錐蟲病治療市場：按產品類型、分銷管道和地區分類

2026年南美錐蟲病治療市場規模估計為1,140萬美元，預計到2033年將達到1,870萬美元。預計2026年至2033年，該市場將以7.3%的複合年成長率成長。

南美錐蟲病是一種熱帶寄生蟲疾病，流行於21個拉丁美洲國家。它可透過輸血、器官移植、先天性性行為感染和口服傳播。雖然南美錐蟲病南美錐蟲病流行於拉丁美洲，但近年來由於拉丁美洲人口向其他國家的遷移，其全球發病率上升。根據世界衛生組織（世衛組織）2018年2月發布的數據，全球約有600萬至700萬人感染了引起南美錐蟲病的寄生蟲－錐蟲（Trypanosoma cludiciformis ）。目前，只有兩種藥物可用於治療南美錐蟲病：苯硝唑和硝呋莫司。

市場動態

預計來自流行國家的移民向美國和歐洲等已開發國家的增加將推動南美錐蟲病治療市場的成長。例如，根據公共科學圖書館（PLOS）發布的數據，截至2012年，約有162,095名玻利維亞成年人居住在西班牙，其中約97,215人為女性（佔60%），64,880人為男性。據估計，從玻利維亞移居西班牙的移民中，可能有34,202人感染了南美錐蟲病。此外，旨在開發南美錐蟲病新治療方法的研發活動的活性化，預計也將為市場成長創造有利環境。例如，2016年，聖路易斯大學疫苗研發中心的研究人員正致力於開發南美錐蟲病疫苗。科學家發現了 Th17 細胞，這是一種特殊的白血球，能夠識別外來入侵者的存在，並幫助免疫系統的其他細胞攻擊錐蟲寄生蟲，從而保護身體。

本報告的主要特點

• 本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
• 此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
• 本節根據各種參數（公司概況、財務表現、產品系列、企業發展區域、分銷策略、主要趨勢和策略、未來計劃等）對全球南美錐蟲病治療市場的主要公司進行介紹。
• 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
• 《全球南美錐蟲病治療市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 相關人員可以透過分析全球南美錐蟲病治療市場中使用的各種策略矩陣來促進決策。

目錄

第1章：分析目標與假設

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 抑制因子
  • 市場機遇
• 診斷需求
• 診斷方法
• 近期產品核可上市
• 管道分析
• 監管趨勢
• PEST分析
• 流行病學

第4章：全球南美錐蟲病治療市場：依產品類型分類（2021-2033 年）

• 苯硝唑
• 尼福替莫

第5章：全球南美錐蟲病治療市場：依分銷管道分類（2021-2033 年）

• 醫院
• 零售藥房
• 網路藥房

第6章：全球南美錐蟲病治療市場：按地區分類（2021-2033 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲國家
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第7章 競爭情勢

• 熱圖分析
• 公司簡介
  • Nortec Quimica SA
  • Bayer AG
  • Laboratorio Elea Phoenix SA
  • Maprimed SA
  • Laboratorio Farmaceutico de Pernambuco S/A

第8章

• 分析方法

Chagas Disease Treatment Market is estimated to be valued at USD 11.4 Mn in 2026 and is expected to reach USD 18.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2026 to 2033.

Chagas disease is a tropical parasitic disease and is endemic in 21 countries in Latin America. Chagas disease can transmitted through blood transfusion, organ transplantation, as well as congenital and oral transmissions. Chagas disease is endemic to Latin America, however, in the recent past, there is a rise in global incidence of Chagas disease due to the migration of Latin American people to other countries. According to data published by World Health Organization (WHO), in February 2018, globally, around 6 Mn to 7 Mn people were infected with Trypansosoma cruzi, the parasite which causes Chagas disease. Benznidazole and Nifurtimox are only two drugs available for the treatment of Chagas disease.

Market Dynamics

Rising migration of people from endemic countries to developed economies such as the U.S. and in countries in Europe is expected to drive growth of Chagas disease treatment market. For instance, according to the data published by Public Library of Science (PLOS), in 2012, there are around 1,62,095 Bolivian adults living in Spain, in which about 97,215 are women (60%) and 64,880 are men. It was estimated that out of total immigrants from Bolivia to Spain 34,202 were found to be potentially infected with Chagas disease. Furthermore, increasing R&D activities for the development of novel treatment methods for Chagas disease is also expected to create a lucrative environment for the market growth. For instance, in 2016, researchers from Saint Louis University Center for Vaccine Development were working on developing a vaccine for Chagas disease. Scientists found Th17 cells, a special type of white blood cell that recognizes the presence of a foreign invader and helps other cells in the immune system to attack and protects the body against Trypanosoma cruzi parasite.

Key features of the study

• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global Chagas disease treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
• Key companies covered as a part of this study include Nortec Quimica SA, Bayer AG, Laboratorio Elea Phoenix SA, Maprimed S.A., and Laboratorio Farmaceutico de Pernambuco S/A.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global Chagas disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the Chagas disease treatment market

Market Segmentation

• By Product Type (Revenue, USD Mn, 2021-2033)
  • Benznidazole
  • Nifurtimox
• By Distribution Channel (Revenue, USD Mn, 2021-2033)
  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies
• By Region (Revenue, USD Mn, 2021-2033)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • Central Africa
  • North Africa
• Key Players
  • Nortec Quimica SA
  • Bayer AG
  • Laboratorio Elea Phoenix SA
  • Maprimed S.A.
  • Laboratorio Farmaceutico de Pernambuco S/A

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Diagnosis Needs
• Diagnosis Methods
• Recent Product Approval/Launch
• Pipeline Analysis
• Regulatory Scenario
• PEST Analysis
• Epidemiology

4. Global Chagas Disease Treatment Market, By Product Type, 2021-2033 (US$ Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Benznidazole
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)
• Nifurtimox
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)

5. Global Chagas Disease Treatment Market, By Distribution Channel, 2021-2033 (US$ Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)

6. Global Chagas Disease Treatment Market, By Region, 2021-2033 (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2022-2033
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2021-2033 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2021-2033 (US$ Mn)
  • Market Size and Forecast, By Country, 2021-2033 (US$ Mn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2021-2033 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2021-2033 (US$ Mn)
  • Market Size and Forecast, By Country, 2021-2033 (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2021-2033 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2021-2033 (US$ Mn)
  • Market Size and Forecast, By Country, 2021-2033 (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2021-2033 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2021-2033 (US$ Mn)
  • Market Size and Forecast, By Country, 2021-2033 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2021-2033 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2021-2033 (US$ Mn)
  • Market Size and Forecast, By Country, 2021-2033 (US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2021-2033 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2021-2033 (US$ Mn)
  • Market Size and Forecast, By Country, 2021-2033 (US$ Mn)
    • South Africa
    • North Africa
    • Central Africa

7. Competitive Landscape

• Heat Map Analysis
• Company Profiles
  • Nortec Quimica SA
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
  • Bayer AG
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Strategies
  • Laboratorio Elea Phoenix SA
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Strategies
  • Maprimed S.A.
    • Company Overview
    • Product Portfolio
    • Manufacturing Capabilities
  • Laboratorio Farmaceutico de Pernambuco S/A
    • Company Overview
    • Product Portfolio
    • Strategies

8. Section

• Research Methodology
• About us and Sales Contact